138 related articles for article (PubMed ID: 31631152)
1. [Successful Treatment of Gastric Cancer with Conversion Surgery after Nivolumab Treatment-A Case Report].
Shiraishi T; Kano M; Sakata H; Murakami K; Toyozumi T; Sekino N; Okada K; Kamata T; Ryuzaki T; Matsubara H
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1614-1616. PubMed ID: 31631152
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Esophagogastric Junction Cancer Treated Successfully with Conversion Surgery after Complete Response to Nivolumab Treatment].
Yamazaki K; Taniguchi K; Yamane M; Hattori Y; Koizumi A; Shigehara F; Takashima J; Sugimoto H; Miura F; Matsutani N; Kobayashi H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2121-2123. PubMed ID: 35045512
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Initially Unresectable Advanced Gastric Cancer Radically Resected by Conversion Surgery after Nivolumab Immunotherapy].
Koizumi N; Kashiwagi S; Ogino S; Kamada Y; Fujiki H; Sakakura C
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1624-1626. PubMed ID: 33268741
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Recurrent Gastric Cancer with Durable Complete Response after Short-Term Nivolumab Therapy].
Yamamichi K; Yamada M; Sumiyama F; Yamamoto N; Hashimoto Y; Satake R; Hatta M; Sakaguchi T; Kotsuka M; Tokuhara K; Inoue K; Sekimoto M
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2052-2054. PubMed ID: 35045490
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Gastric Cancer with Continued Progression-Free Survival Even after Total Gastrectomy and Nivolumab Therapy].
Fujii H; Choda Y; Kubota T; Ishida M; Sato D; Sumitani D; Yoshimitsu M; Nakano K; Harano M; Matsukawa H; Idani H; Shiozaki S; Okajima M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2318-2320. PubMed ID: 32156917
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Unresectable Advanced Gastric Neuroendocrine Cell Carcinoma Treated with Nivolumab].
Yoshioka R; Nagase H; Noguchi K; Hamabe A; Hirota M; Oshima K; Tanida T; Ogino T; Tomimaru Y; Kawase T; Noura S; Imamura H; Iwasawa T; Akagi K; Ando H; Tamura H; Adachi S; Dono K
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1530-1532. PubMed ID: 30382068
[TBL] [Abstract][Full Text] [Related]
7. Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report.
Komo T; Suzuki T; Tazawa H; Sada H; Morimoto H; Shimada N; Hadano N; Onoe T; Sudo T; Shimizu Y; Tashiro H
Int J Surg Case Rep; 2021 Jul; 84():106161. PubMed ID: 34237686
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Advanced Gastric Cancer in Which Tumor Relapse Was Observed after Discontinuation of Nivolumab Due to Complete Response, and for Which Re-Administration Was Initiated].
Nishida K; Yagi H; Mizumoto R; Haeno M; Mori S; Nomura M; Yasuyama A; Yoshikawa Y; Sueda T; Matsumura T; Koga C; Miyagaki H; Tei M; Tsujie M; Akamaru Y
Gan To Kagaku Ryoho; 2023 Mar; 50(3):343-345. PubMed ID: 36927904
[TBL] [Abstract][Full Text] [Related]
9. Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy.
Watanabe H; Fujikawa H; Komori K; Kano K; Takahashi K; Yamada T; Inokuchi Y; Machida N; Yokose T; Rino Y; Masuda M; Ogata T; Oshima T
Case Rep Gastroenterol; 2021; 15(2):562-567. PubMed ID: 34616257
[TBL] [Abstract][Full Text] [Related]
10. [Palliative Radiotherapy and Sequential Nivolumab Administration for Recurrent Gastric Cancer-A Case Report].
Hamakawa T; Nishikawa K; Tanaka E; Nagae A; Toshiyama R; Miyo M; Fujiwara A; Miyake M; Hama N; Miyamoto A; Kato T; Takami K; Hirao M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2557-2559. PubMed ID: 32156997
[TBL] [Abstract][Full Text] [Related]
11. Successful Conversion Surgery Following Chylous Ascites After Nivolumab for Advanced Gastric Cancer.
Toyota S; Orita H; Fukuyama Y; Motoyoshi S; Kawanami S; Maeda S; Kuramitsu E; Ichimanda M; Nagamatsu S; Nagata S; Kai S; Korenaga D; Mori M
In Vivo; 2020; 34(2):583-585. PubMed ID: 32111756
[TBL] [Abstract][Full Text] [Related]
12. A case of gastric cancer with delayed onset of tumor reduction effect by nivolumab therapy.
Satoyoshi R; Muto O; Masuda A; Kotanagi K; Kichiraku T; Kudoh K; Sawada T; Miyazawa H; Kotanagi H
Clin J Gastroenterol; 2019 Feb; 12(1):15-19. PubMed ID: 30206777
[TBL] [Abstract][Full Text] [Related]
13. Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report.
Takami T; Yasuda K; Uozumi N; Musiake Y; Shintani H; Kataoka N; Yamaguchi T; Makimoto S
J Med Case Rep; 2021 Dec; 15(1):604. PubMed ID: 34930435
[TBL] [Abstract][Full Text] [Related]
14. [Nivolumab Therapy for Synchronous Double Primary Lung and Gastric Cancers].
Hachisuka Y; Fujioka S; Uomoto M; Johira H
Gan To Kagaku Ryoho; 2020 Dec; 47(12):1711-1714. PubMed ID: 33342989
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Conversion Surgery after SOX plus Nivolumab for Unresectable Advanced Gastric Cancer].
Sato T; Kawaoka T; Xaolin Y; Matsukuma S; Tokunou K; Yamamoto S
Gan To Kagaku Ryoho; 2024 Jan; 51(1):75-77. PubMed ID: 38247097
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Long-Term Progress Control of Unresectable Progressive Gastric Cancer with Nivolumab Introduced during Effective Duration of Secondary Treatment].
Eguchi S; Akamaru Y; Wada N; Shimaoka T; Harada S; Ikeshima R; Munakata K; Takiuchi D; Hama N; Ota H; Shibata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2045-2047. PubMed ID: 35045488
[TBL] [Abstract][Full Text] [Related]
17. [Locally Advanced Gastric Cancer Showing Marked Tumor Shrinkage after the First Dose of Nivolumab for Fourth-Line Chemotherapy].
Ochi S; Kadokawa Y; Iwasaki Y; Yamanaka R; Nakanishi N; Matsumura S; Kitano T; Horie H; Takamatsu Y; Nakano K; Goto T; Kato S; Saito S; Tanaka H; Machimoto T
Gan To Kagaku Ryoho; 2021 Sep; 48(9):1161-1163. PubMed ID: 34521796
[TBL] [Abstract][Full Text] [Related]
18. [A case of gastric cancer treated with nivolumab in which the sIL-2R/ lymphocyte ratio changed with tumor status].
Masui M; Tamura Y; Funatsuya T; Fujii Y; Takahashi M
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(8):768-774. PubMed ID: 34373396
[TBL] [Abstract][Full Text] [Related]
19. [Nivolumab Treatment for the Patients with Gastric Cancer-Present and Future].
Imazeki H; Kato K; Boku N
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1513-1523. PubMed ID: 31631132
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis.
Kono M; Sakurai T; Okamoto K; Masaki S; Nagai T; Komeda Y; Kamata K; Minaga K; Yamao K; Takenaka M; Watanabe T; Nishida N; Kudo M
Intern Med; 2019 May; 58(9):1263-1266. PubMed ID: 30626829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
